Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses. Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • PAVEY T
    • DR Obi Ukoumunne
    • GARSIDE R
    • ANDERSON R
    • HOYLE M
    • CIANI O
    • CRATHORNE L
    • JONES-HUGHES T
    • COOPER C
    • OSIPENKO L
    • VENKATACHALAM M
    • RUDIN C

Time

Date/time value

  • 2012

Identity

Digital Object Identifier (DOI)

  • 10.3310/hta16420

Additional Document Info

Parent Title

  • Health Technol Assess

Volume

  • 16

Issue

  • 42

Publisher

  • publisher